This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universiti Putra Malaysia. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Innovations of Mohamed Rajik in Avian Influenza Research
Introduction
Mohamed Rajik is an accomplished inventor based in Serdang, Malaysia. He has made significant contributions to the field of virology, particularly in the development of therapeutic agents against avian influenza.
Latest Patents
His notable patent is titled "Antiviral peptide against avian influenza virus H9N2." This invention relates to recombinant phages carrying fusion peptides that bind to avian influenza virus (AIV). These phages serve as diagnostic reagents, replacing anti-AIV antibodies by competing for binding sites on the virus. The synthetic peptides with the sequence CNDFRSKTC, in either linear or cyclic conformations, or fusion phages bearing these peptides, have shown effectiveness in inhibiting AIV propagation in embryonated eggs and MDCK cell lines. Therefore, they may be utilized as therapeutic agents to control, treat, and eradicate bird flu caused by avian influenza virus.
Career Highlights
Mohamed Rajik is affiliated with Universiti Putra Malaysia, where he continues to engage in innovative research. His work has garnered attention for its potential impact on public health and disease management.
Collaborations
He has collaborated with notable colleagues, including Khatijah Mohd Yusoff and Abdul Rahman Omar, contributing to the advancement of research in his field.
Conclusion
Mohamed Rajik's innovative work in developing antiviral peptides against avian influenza showcases his commitment to addressing significant health challenges. His contributions are vital in the ongoing fight against viral infections.